THERASONIC LITHOTRIPSY TREATMENT SYSTEM

FDA Premarket Approval P890066 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceTHERASONIC LITHOTRIPSY TREATMENT SYSTEM
Generic NameLithotriptor, Extracorporeal Shock-wave, Urological
ApplicantFOCUS SURGERY, INC.
Date Received1991-11-19
Decision Date1992-10-29
PMAP890066
SupplementS003
Product CodeLNS 
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address FOCUS SURGERY, INC. 1565 Barber Ln. milpitas, CA 95035

Supplemental Filings

Supplement NumberDateSupplement Type
P890066Original Filing
S005 1994-02-15 Normal 180 Day Track
S004 1992-03-10 Normal 180 Day Track
S003 1991-11-19 Normal 180 Day Track
S002
S001 1991-10-24 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.